Adult Sensory Processing Scale (ASPS) Version of Turkish
NCT ID: NCT04713839
Last Updated: 2021-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
405 participants
OBSERVATIONAL
2019-04-01
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability and Validity of the Turkish Version of Sensory Hypersensivity Scale
NCT04776707
Reliability and Validity of the Turkish Version of the Sensory Eating Problems Scale
NCT03987984
The Effect of Occupational Therapy-Based Instrumental Activities of Daily Living Intervention in People With Disabilities
NCT05790798
Validity and Reliability of the Turkish Version of the 4-Item Short Form of the Pain Anxiety Symptom Scale
NCT06758973
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
NCT05970692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phase 1: The cross-cultural adaptation process Translating the Turkish version of ASPS and the cross-cultural adaptation procedure was carried out under the guidance of Beaton et al. Translation from English to Turkish was performed by two therapists whose mother tongue is Turkish, also have fluent in English. Each of the translations was reviewed by three therapists, after the consensus on the final version, it was turned down by two native English-speaking translators. The final version was compared with the original version to reveal any inconsistencies; no discrepancies were observed. During the translation phase, minimal adjust were made to address linguistic.
Phase 2: Piloting process A pre-assessment was made with a pilot study to explore ASPS-Turkish's cultural harmony. The translated questionnaire was completed by 20 participants to identify any items that were not coherent. Four participants stated that they could not understand the meaning of avoid-kaçınmak, so investigators suggested yaşamamak, and this was accepted by participants. Three participants could not respond to the first item on factor 10, because participants had not traveled by boat or rides before, so that, investigators added the phrase "all types of vehicles" was added to the sentence. All the authors meet to compare the ASPS-T with the original version and assess its suitability after the minimal change, concluding that the current correction did not cause any loss of the meaning of the word. After the changes, pilot study participants evaluated the intelligibility of the scale with a 1 to 5 Likert scale, and confirm the clearness unanimously of them. Therefore, the final version of the ASPS-T which has minor changes was the best representation of the original, and each item was found to be suitable for Turkish patients. The pilot study participants were not included in the sample. After cultural equivalence had been achieved, 405 healthy individuals aged 18 and over were asked to complete the ASPS questionnaire.
Phase 3: Analysis of psychometric properties Exploratory and Confirmatory Factor Analysis (EFA and CFA) were used to measure the construct validity of the instrument, and test-retest analysis (interclass correlation coefficient) and Cronbach's alpha were used to evaluate the reliability of the instrument.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
The participants were invited to the study, then each participant was asked to complete the self-report questionnaires.
no intervention
We didn't have an intervention program, we used two questionnaires to evaluate participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
We didn't have an intervention program, we used two questionnaires to evaluate participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Uskudar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZEYNEP BAHADIR AGCE
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ORKUN ARAN, PHD
Role: STUDY_CHAIR
Hacettepe University
SEDEF ŞAHİN, PHD
Role: STUDY_CHAIR
Hacettepe University
ZEYNEP BAHADIR AGCE, PHD
Role: STUDY_DIRECTOR
Uskudar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uskudar University
Istanbul, State, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Blanche EI, Parham D, Chang M, Mallinson T. Development of an Adult Sensory Processing Scale (ASPS). Am J Occup Ther. 2014 Sep-Oct;68(5):531-8. doi: 10.5014/ajot.2014.012484.
Related Links
Access external resources that provide additional context or updates about the study.
PUBMED LINK
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
61351342-193
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.